loading...

Injection Treatment Acceptance Questionnaire (I-TAQ)

Sanofi Aventis

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • Published in 2015
Authors

Sanofi Aventis

Copyright
I-TAQ © Version 1, 13 March 2015 Sanofi and Regeneron Pharmaceuticals Inc. All Rights Reserved.
Objective
To assess treatment acceptance with a subcutaneous injection therapy for an asymptomatic condition
Therapeutic area
  • Generic
Therapeutic indication

All

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Tatlock S, Grant L, Spertus JA, Khan I, Arbuckle R, Manvelian G, Sanchez RJ. Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection. Value Health. 2015 Dec;18(8):1000-7 (Full text article)

Tatlock S, Arbuckle R, Sanchez R, Grant L, Khan I, Manvelian G, Spertus JA. Psychometric Evaluation of a Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection. Value Health. 2017 Mar;20(3):430-440 (Full text article)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Sanofi Aventis

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

I-TAQ_AU1.0

Afrikaans for South Africa
Arabic for Israel
Arabic for Kuwait
Arabic for Lebanon
Arabic for Saudi Arabia
Arabic for the United Arab Emirates
Catalan for Spain
Chinese for China
Chinese for Hong Kong
Chinese for Taiwan
Danish for Denmark
Dutch for Belgium (Flemish)
Dutch for the Netherlands
English for Canada
English for the UK
Finnish for Finland
French for Belgium
French for Canada
French for France
French for Switzerland
German for Germany
German for Switzerland
Greek for Greece
Hebrew for Israel
Hungarian for Hungary
Italian for Italy
Italian for Switzerland
Korean for Korea
Norwegian for Norway
Portuguese for Brazil
Russian for Russia
Spanish for Spain
Spanish for the USA
Swedish for Sweden
Turkish for Turkey
Ukrainian for Russia

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation:

Not authorized

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us